MMM 3M

FY2025 10-K
Filed: Feb 3, 2026
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR

3M (MMM) filed its fiscal year 2025 10-K annual report with the SEC on Feb 3, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business: Diversified technology company focused on innovation and ethical conduct across multiple industries
  • Strategic divestiture: Separation and distribution of Solventum Corporation completed in March 2024, with multiple transition agreements executed
+3 more insights

Management Discussion & Analysis

  • Revenue $35.4B, declined 4% YoY from $36.9B in prior year
  • Operating margin 18.2% vs 19.7% prior year, decrease driven by increased costs
+3 more insights

Risk Factors

  • Regulatory/legal risk: 2025 PFAS-related New Jersey Settlement litigation and site remediation obligations increasing net costs and impacting operating income
  • Geopolitical/macro risk: EMEA region organic sales declined 1.7% in 2025, with ongoing tariff impacts raising cost of sales
+3 more insights

Financial Summary
XBRL

Revenue

$24.9B

Net Income

$3.3B

Operating Margin

18.6%

Net Margin

13.0%

ROE

69.1%

Total Assets

$37.7B

EPS (Diluted)

$6.00

Operating Cash Flow

$2.3B

Source: XBRL data from 3M FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on 3M

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available